|
|
drug metabolic process
|
GO:0017144 |
4 |
0.765
|
Mouse Rat |
|
|
vitamin d3 metabolic process
|
GO:0070640 |
3 |
0.681
|
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.434
|
|
|
|
drug catabolic process
|
GO:0042737 |
2 |
0.322
|
Mouse |
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.292
|
|
|
|
secondary alcohol metabolic process
|
GO:1902652 |
3 |
0.277
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.258
|
|
|
|
naphthalene containing compound metabolic process
|
GO:0090420 |
1 |
0.256
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.256
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.251
|
Mouse Rat |
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.231
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.229
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.224
|
|
|
|
cellular alcohol metabolic process
|
GO:0044107 |
3 |
0.222
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.222
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.214
|
|
|
|
calcitriol biosynthetic process from calciol
|
GO:0036378 |
3 |
0.198
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.184
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.173
|
|
|
|
cellular alcohol biosynthetic process
|
GO:0044108 |
3 |
0.167
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.162
|
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.145
|
|
|
|
renal tubular secretion
|
GO:0097254 |
2 |
0.142
|
|
|
|
naphthalene metabolic process
|
GO:0018931 |
1 |
0.117
|
|
|
|
fatty acid derivative metabolic process
|
GO:1901568 |
33 |
0.117
|
|
|
|
regulation of estrogen secretion
|
GO:2000861 |
1 |
0.117
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.116
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.114
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.113
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.110
|
|
|
|
icosanoid metabolic process
|
GO:0006690 |
33 |
0.103
|
|
|
|
unsaturated fatty acid metabolic process
|
GO:0033559 |
31 |
0.101
|
|
|
|
arachidonic acid metabolic process
|
GO:0019369 |
14 |
0.100
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.100
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.099
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.099
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.097
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.095
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.094
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.092
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.092
|
|
|
|
positive regulation of steroid hormone secretion
|
GO:2000833 |
2 |
0.091
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.091
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.086
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.084
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.081
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.080
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.080
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.079
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.076
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.074
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.060
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.060
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.060
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.057
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.057
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.056
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.055
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.054
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.054
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.054
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.053
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.053
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.052
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.051
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.050
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.049
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.048
|
|
|
|
positive regulation of estrogen secretion
|
GO:2000863 |
1 |
0.047
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.046
|
|
|
|
pilomotor reflex
|
GO:0097195 |
3 |
0.046
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.044
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.044
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.044
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.044
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.043
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.042
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.041
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.041
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.040
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.040
|
|
|
|
estrogen secretion
|
GO:0035937 |
1 |
0.039
|
|
|
|
innate immune response in mucosa
|
GO:0002227 |
3 |
0.039
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.039
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.039
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.039
|
|
|
|
regulation of t cell extravasation
|
GO:2000407 |
3 |
0.039
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.038
|
|
|
|
tetrapyrrole metabolic process
|
GO:0033013 |
22 |
0.038
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.038
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.038
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.037
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.037
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.037
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.036
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.036
|
|
|
|
xenobiotic catabolic process
|
GO:0042178 |
1 |
0.036
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.036
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.035
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.035
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.035
|
|
|
|
positive regulation of heart rate by epinephrine norepinephrine
|
GO:0001996 |
4 |
0.035
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.035
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.035
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.034
|
|
|
|
exogenous drug catabolic process
|
GO:0042738 |
1 |
0.034
|
|
|
|
nucleus accumbens development
|
GO:0021768 |
1 |
0.033
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.033
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.033
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.033
|
|
|
|
coenzyme metabolic process
|
GO:0006732 |
52 |
0.033
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.033
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.033
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.033
|
|
|
|
positive regulation of blood pressure
|
GO:0045777 |
21 |
0.033
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.033
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.033
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.032
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.032
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.032
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.032
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.032
|
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.032
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.032
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.032
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.031
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.031
|
|
|
|
angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure
|
GO:0001998 |
3 |
0.031
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.031
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.030
|
|
|
|
positive regulation of the force of heart contraction by epinephrine norepinephrine
|
GO:0001997 |
3 |
0.030
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.030
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.030
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.030
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.030
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.029
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.029
|
|
|
|
pyridine containing compound metabolic process
|
GO:0072524 |
14 |
0.029
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.029
|
|
|
|
vitamin metabolic process
|
GO:0006766 |
23 |
0.028
|
|
|
|
cd8 positive alpha beta t cell extravasation
|
GO:0035697 |
3 |
0.028
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.028
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.028
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.028
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.028
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.027
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.027
|
|
|
|
positive regulation of the force of heart contraction by chemical signal
|
GO:0003099 |
3 |
0.027
|
|
|
|
long chain fatty acid metabolic process
|
GO:0001676 |
26 |
0.027
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.027
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.027
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.027
|
|
|
|
hematopoietic stem cell migration
|
GO:0035701 |
1 |
0.026
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.026
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.026
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.026
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.025
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.025
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.025
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.025
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.024
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.024
|
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.024
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.024
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.024
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.024
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.024
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.024
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.024
|
|
|
|
polyol metabolic process
|
GO:0019751 |
26 |
0.023
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.023
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.023
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.023
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.023
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.023
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.023
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.023
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.023
|
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.023
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.023
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.023
|
|
|
|
response to nitrosative stress
|
GO:0051409 |
1 |
0.023
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.023
|
|
|
|
t cell extravasation
|
GO:0072683 |
4 |
0.023
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.023
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.023
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.022
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.022
|
|
|
|
aldehyde catabolic process
|
GO:0046185 |
4 |
0.022
|
|
|
|
regulation of monocyte chemotaxis
|
GO:0090025 |
3 |
0.022
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.022
|
|
|
|
steroid biosynthetic process
|
GO:0006694 |
47 |
0.022
|
|
|
|
positive regulation of t cell costimulation
|
GO:2000525 |
2 |
0.022
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.022
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.022
|
|
|
|
positive regulation of monocyte extravasation
|
GO:2000439 |
1 |
0.022
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.022
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.021
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.021
|
|
|
|
regulation of immunological synapse formation
|
GO:2000520 |
2 |
0.021
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.021
|
|
|
|
eosinophil mediated immunity
|
GO:0002447 |
1 |
0.021
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.021
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.021
|
|
|
|
positive regulation of hormone metabolic process
|
GO:0032352 |
3 |
0.021
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.021
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.021
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.021
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.021
|
|
|
|
vasodilation by norepinephrine epinephrine involved in regulation of systemic arterial blood pressure
|
GO:0002025 |
3 |
0.021
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.021
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.021
|
|
|
|
negative regulation of serotonin secretion
|
GO:0014063 |
2 |
0.021
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.021
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.021
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.021
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.021
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.021
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.021
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.020
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.020
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.020
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.020
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.020
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.020
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.020
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.020
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.020
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.020
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.020
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.020
|
|
|
|
positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation
|
GO:2000526 |
1 |
0.020
|
|
|
|
porphyrin containing compound metabolic process
|
GO:0006778 |
22 |
0.019
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.019
|
|
|
|
operant conditioning
|
GO:0035106 |
2 |
0.019
|
|
|
|
regulation of interferon gamma production
|
GO:0032649 |
57 |
0.019
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.019
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.019
|
|
|
|
regulation of macrophage activation
|
GO:0043030 |
17 |
0.019
|
|
|
|
protein kinase c activating g protein coupled receptor signaling pathway
|
GO:0007205 |
4 |
0.019
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.019
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.019
|
|
|
|
iron ion homeostasis
|
GO:0055072 |
36 |
0.019
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.019
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.019
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.019
|
|
|
|
t helper 17 cell chemotaxis
|
GO:0035705 |
1 |
0.019
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.019
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.019
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.018
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.018
|
|
|
|
positive regulation of immunological synapse formation
|
GO:2000522 |
1 |
0.018
|
|
|
|
monovalent inorganic cation homeostasis
|
GO:0055067 |
33 |
0.018
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.018
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.018
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.018
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.018
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.018
|
|
|
|
pigment metabolic process
|
GO:0042440 |
32 |
0.018
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.018
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.018
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.018
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.018
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.018
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.018
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.018
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.018
|
|
|
|
sulfate assimilation
|
GO:0000103 |
3 |
0.018
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.018
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.018
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.018
|
|
|
|
macrophage activation
|
GO:0042116 |
27 |
0.017
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.017
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.017
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.017
|
|
|
|
monocyte extravasation
|
GO:0035696 |
2 |
0.017
|
|
|
|
response to stilbenoid
|
GO:0035634 |
22 |
0.017
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.017
|
|
|
|
negative regulation of systemic arterial blood pressure
|
GO:0003085 |
15 |
0.017
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.017
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.017
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.017
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.017
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.017
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.017
|
|
|
|
helper t cell chemotaxis
|
GO:0035704 |
1 |
0.017
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.017
|
|
|
|
chemokine mediated signaling pathway
|
GO:0070098 |
17 |
0.017
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.017
|
|
|
|
multicellular organismal metabolic process
|
GO:0044236 |
28 |
0.017
|
|
|
|
habituation
|
GO:0046959 |
3 |
0.017
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.017
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.017
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.017
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.017
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.017
|
|
|
|
heme metabolic process
|
GO:0042168 |
16 |
0.016
|
|
|
|
planar cell polarity pathway involved in heart morphogenesis
|
GO:0061346 |
3 |
0.016
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.016
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.016
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.016
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.016
|
|
|
|
organ regeneration
|
GO:0031100 |
2 |
0.016
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.016
|
|
|
|
response to phenylpropanoid
|
GO:0080184 |
22 |
0.016
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.016
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.016
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.016
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.016
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.016
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.016
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.016
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.016
|
|
|
|
regulation of thyroid hormone generation
|
GO:2000609 |
4 |
0.016
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.016
|
|
|
|
regulation of phospholipase c activity
|
GO:1900274 |
3 |
0.016
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.016
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.016
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.016
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.016
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.016
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.016
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.015
|
|
|
|
positive regulation of thyroid hormone generation
|
GO:2000611 |
2 |
0.015
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.015
|
|
|
|
negative regulation of eosinophil degranulation
|
GO:0043310 |
1 |
0.015
|
|
|
|
regulation of cell cell adhesion mediated by cadherin
|
GO:2000047 |
2 |
0.015
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.015
|
|
|
|
regulation of regulated secretory pathway
|
GO:1903305 |
20 |
0.015
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.015
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.015
|
|
|
|
interferon gamma production
|
GO:0032609 |
67 |
0.015
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.015
|
|
|
|
regulation of acute inflammatory response to antigenic stimulus
|
GO:0002864 |
10 |
0.015
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.015
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.015
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.015
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.015
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.015
|
|
|
|
histamine induced gastric acid secretion
|
GO:0001697 |
1 |
0.015
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.015
|
|
|
|
negative regulation of intrinsic apoptotic signaling pathway
|
GO:2001243 |
34 |
0.015
|
|
|
|
regulation of serotonin secretion
|
GO:0014062 |
3 |
0.015
|
|
|
|
regulated secretory pathway
|
GO:0045055 |
32 |
0.015
|
|
|
|
immune complex clearance by monocytes and macrophages
|
GO:0002436 |
2 |
0.015
|
|
|
|
regulation of systemic arterial blood pressure by renin angiotensin
|
GO:0003081 |
20 |
0.015
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.014
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.014
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.014
|
|
|
|
regulation of cd8 positive alpha beta t cell extravasation
|
GO:2000449 |
3 |
0.014
|
|
|
|
interaction with symbiont
|
GO:0051702 |
14 |
0.014
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.014
|
|
|
|
nicotinamide nucleotide metabolic process
|
GO:0046496 |
12 |
0.014
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.014
|
|
|
|
response to xenobiotic stimulus
|
GO:0009410 |
13 |
0.014
|
|
|
|
positive regulation of immune complex clearance by monocytes and macrophages
|
GO:0090265 |
2 |
0.014
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.014
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.014
|
|
|
|
endothelial cell proliferation
|
GO:0001935 |
27 |
0.014
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.014
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.014
|
|
|
|
positive regulation of t cell receptor signaling pathway
|
GO:0050862 |
4 |
0.014
|
|
|
|
positive regulation of phagocytosis
|
GO:0050766 |
26 |
0.014
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.014
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.014
|
|
|
|
oxidoreduction coenzyme metabolic process
|
GO:0006733 |
16 |
0.014
|
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
47 |
0.014
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.014
|
|
|
|
gastrin induced gastric acid secretion
|
GO:0001698 |
1 |
0.014
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.014
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.014
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.014
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
31 |
0.014
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.014
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.013
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.013
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.013
|
|
|
|
immune complex clearance
|
GO:0002434 |
2 |
0.013
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.013
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.013
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.013
|
|
|
|
linoleic acid metabolic process
|
GO:0043651 |
6 |
0.013
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.013
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.013
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.013
|
|
|
|
medium chain fatty acid metabolic process
|
GO:0051791 |
1 |
0.013
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.013
|
|
|
|
transition metal ion homeostasis
|
GO:0055076 |
54 |
0.013
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
68 |
0.013
|
|
|
|
response to testosterone
|
GO:0033574 |
3 |
0.013
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.013
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.013
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.013
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.013
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.013
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.013
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.013
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.013
|
|
|
|
regulation of appetite
|
GO:0032098 |
12 |
0.013
|
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.013
|
|
|
|
myeloid leukocyte mediated immunity
|
GO:0002444 |
42 |
0.013
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.013
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.013
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.013
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.013
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.013
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.013
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.012
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.012
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.012
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.012
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.012
|
|
|
|
eosinophil activation
|
GO:0043307 |
1 |
0.012
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.012
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.012
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.012
|
|
|
|
regulation of immune complex clearance by monocytes and macrophages
|
GO:0090264 |
2 |
0.012
|
|
|
|
short chain fatty acid catabolic process
|
GO:0019626 |
2 |
0.012
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.012
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.012
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.012
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.012
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.012
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.012
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.012
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.012
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.012
|
|
|
|
positive regulation of lipid transport
|
GO:0032370 |
22 |
0.012
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.012
|
|
|
|
terpenoid metabolic process
|
GO:0006721 |
25 |
0.012
|
|
|
|
camp metabolic process
|
GO:0046058 |
40 |
0.012
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.012
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.012
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.012
|
|
|
|
microglial cell activation
|
GO:0001774 |
3 |
0.012
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.012
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.012
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.012
|
|
|
|
eosinophil degranulation
|
GO:0043308 |
1 |
0.012
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.012
|
|
|
|
interleukin 12 secretion
|
GO:0072610 |
3 |
0.012
|
|
|
|
regulation of myeloid leukocyte mediated immunity
|
GO:0002886 |
25 |
0.012
|
|
|
|
regulation of monocyte extravasation
|
GO:2000437 |
2 |
0.012
|
|
|
|
regulation of cytokine biosynthetic process
|
GO:0042035 |
59 |
0.012
|
|
|
|
protein activation cascade
|
GO:0072376 |
19 |
0.012
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.012
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.012
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.012
|
|
|
|
regulation of endothelial cell proliferation
|
GO:0001936 |
23 |
0.012
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.012
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.012
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.011
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.011
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.011
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.011
|
|
|
|
positive regulation of hematopoietic stem cell migration
|
GO:2000473 |
1 |
0.011
|
|
|
|
amino acid transmembrane transport
|
GO:0003333 |
37 |
0.011
|
|
|
|
negative regulation of leukocyte mediated immunity
|
GO:0002704 |
29 |
0.011
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.011
|
|
|
|
positive regulation of glycolytic process
|
GO:0045821 |
4 |
0.011
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.011
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.011
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.011
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.011
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.011
|
|
|
|
regulation of dendritic cell chemotaxis
|
GO:2000508 |
1 |
0.011
|
|
|
|
positive regulation of interferon gamma production
|
GO:0032729 |
39 |
0.011
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.011
|
|
|
|
cellular response to temperature stimulus
|
GO:0071502 |
2 |
0.011
|
|
|
|
microglial cell activation involved in immune response
|
GO:0002282 |
1 |
0.011
|
|
|
|
regulation of hypersensitivity
|
GO:0002883 |
10 |
0.011
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.011
|
|
|
|
thymic t cell selection
|
GO:0045061 |
22 |
0.011
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.011
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.011
|
|
|
|
regulation of phospholipase a2 activity
|
GO:0032429 |
3 |
0.011
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.011
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.011
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.011
|
|
|
|
vitamin biosynthetic process
|
GO:0009110 |
7 |
0.011
|
|
|
|
nadp metabolic process
|
GO:0006739 |
6 |
0.011
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.011
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.011
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.011
|
|
|
|
positive regulation of dendritic cell chemotaxis
|
GO:2000510 |
1 |
0.011
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.011
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.011
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.011
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.011
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.011
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.011
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.011
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.011
|
|
|
|
positive regulation of t cell extravasation
|
GO:2000409 |
2 |
0.011
|
|
|
|
l amino acid transport
|
GO:0015807 |
32 |
0.011
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.011
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.011
|
|
|
|
cellular response to metal ion
|
GO:0071248 |
31 |
0.011
|
|